Results 111 to 120 of about 6,750 (143)

Bimekizumab plus topical photochemotherapy effective in palmoplantar pustulosis in a patient with hidradenitis suppurativa. [PDF]

J Dtsch Dermatol Ges
Cramer N, Mohr J, Schön MP, Mössner R.
europepmc   +1 more source

Ultraviolet A1-LED Phototherapy for the Treatment of Palmoplantar Pustulosis. [PDF]

Photodermatol Photoimmunol Photomed
Watanabe O, Enomoto Y, Sakurai M, Sakaida T, Yamamoto A, Morita A.   +5 more
europepmc   +1 more source

Hypopyon Sign in Acral Lesions: Dermoscopic Findings of a Patient with Palmoplantar Pustulosis. [PDF]

Curr Health Sci J
Yorulmaz A.
europepmc   +1 more source

Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial. [PDF]

JAAD Int
Ramessur R, Chiesa Fuxench ZC, Shin D, Mason JB, Mason AC, Papadopoulos M, de Oliveira Wafae BG, Noe MH, Gelfand JM.   +8 more
europepmc   +1 more source

Real-world experience of the efficacy and safety of guselkumab 100 mg in patients with palmoplantar pustulosis in Korea: A retrospective single-center study

JAAD International
Min Kyung Cho, MD, Dong Hyun Kim, MD
doaj   +1 more source

Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis. [PDF]

JCI Insight
Do TH, Bogle R, Zhang H, Xing X, Gharaee-Kermani M, Raducu M, Fox J, Jiang R, Plazyo O, Harms PW, Nakamura M, Xing E, Gilliet M, Billi AC, Kahlenberg JM, Modlin RL, Uluckan O, Tsoi LC, Gudjonsson JE.   +18 more
europepmc   +1 more source

Emerging Therapies for Palmoplantar Pustulosis with a Focus on IL-23 Inhibitors. [PDF]

J Clin Med
Nam KH, Kim YS.
europepmc   +1 more source

Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study. [PDF]

J Dermatol
Jo SJ, Kim BS, Kim DH, Kim JH, Park CW, Son SW, Ahn J, Lee JY, Jeong KH, Kim Y, An J, Park CJ, Youn SW.   +12 more
europepmc   +1 more source

Intralesional Spesolimab: A Novel and Effective Approach for Palmoplantar Pustulosis Treatment - A Case Report. [PDF]

Int Med Case Rep J
Wang SN, Lu YZ, Zhao Y, Cao W, Zhang RL.
europepmc   +1 more source

Pyoderma gangrenosum triggered by secukinumab in a patient with palmoplantar pustulosis. [PDF]

An Bras Dermatol
Wang H, Sun J.
europepmc   +1 more source